Tang Capital Management’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Tang Capital Management’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,255,026	Closed	-$13.2M	–	142
2023 Q4	$13.2M	Buy	+3,255,026	New	+$9.93M	1.22%	23

Tang Capital Management's THRX Position: Q1 2024 in Review

Tang Capital Management sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 3,255,026 shares — an estimated $13.2M sold.

Tang Capital Management first reported a position in THRX in Q4 2023 and held it in 1 quarter. The position peaked at $13.2M in Q4 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

Tang Capital Management reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Tang Capital Management sold 3,255,026 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $13.2M.
Tang Capital Management first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Tang Capital Management's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $13.2M in Q4 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Tang Capital Management's 13F filing for Q1 2024, filed 15 May 2024.